ClearPoint Neuro, Inc.
CLPT
$17.88
-$0.10-0.56%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.68% | -32.17% | -0.93% | 3.14% | -11.88% |
| Total Depreciation and Amortization | 8.51% | 76.53% | -31.95% | 87.43% | -29.09% |
| Total Amortization of Deferred Charges | 177.87% | 212.82% | 85.71% | -- | -- |
| Total Other Non-Cash Items | 20.20% | -5.85% | -4.14% | 14.87% | 11.02% |
| Change in Net Operating Assets | 69.91% | -20,960.00% | -117.77% | 107.56% | -248.18% |
| Cash from Operations | 34.05% | -287.06% | -22.30% | 58.65% | -396.54% |
| Capital Expenditure | -1,216.33% | 75.38% | -118.68% | 50.27% | 30.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -159.28% | 646.73% | -118.68% | 50.27% | 30.42% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -54.60% | -- | -100.00% | 17,052.38% | -82.64% |
| Repurchase of Common Stock | -922.05% | -- | 100.00% | 72.72% | -1,453.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Financing | -109.43% | -- | -100.00% | 2,447.80% | -3,781.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -221.99% | 358.19% | -111.32% | 480.12% | -425.32% |